R. Massingham

2.6k total citations
86 papers, 2.1k citations indexed

About

R. Massingham is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Massingham has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Massingham's work include Receptor Mechanisms and Signaling (33 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neuropeptides and Animal Physiology (11 papers). R. Massingham is often cited by papers focused on Receptor Mechanisms and Signaling (33 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neuropeptides and Animal Physiology (11 papers). R. Massingham collaborates with scholars based in Belgium, France and Spain. R. Massingham's co-authors include Salomón Z. Langer, Pierre Chatelain, N B Shepperson, Icilio Cavero, D. Cambridge, Michel Gillard, F Lefèvre-Borg, Michael Davey, Nicole Moguilevsky and Margareta Hammarlund‐Udenaes and has published in prestigious journals such as Hypertension, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R. Massingham

83 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Massingham Belgium 27 966 614 543 316 167 86 2.1k
Katsuji Oguchi Japan 28 920 1.0× 455 0.7× 399 0.7× 217 0.7× 93 0.6× 175 2.4k
A Giotti Italy 28 968 1.0× 736 1.2× 1.0k 1.9× 344 1.1× 95 0.6× 128 2.6k
G. Zürcher Switzerland 27 888 0.9× 553 0.9× 318 0.6× 305 1.0× 162 1.0× 42 3.0k
J B Farmer United Kingdom 24 625 0.6× 359 0.6× 795 1.5× 362 1.1× 99 0.6× 55 2.2k
Jan M. Van Nueten Belgium 28 1.3k 1.3× 1.4k 2.2× 758 1.4× 407 1.3× 195 1.2× 65 3.2k
Kazutaka Momose Japan 25 1.2k 1.2× 317 0.5× 580 1.1× 179 0.6× 77 0.5× 143 2.0k
Hsien C. Cheng United States 21 530 0.5× 270 0.4× 263 0.5× 309 1.0× 103 0.6× 53 1.4k
Stefano Evangelista Italy 32 819 0.8× 1.0k 1.7× 714 1.3× 445 1.4× 94 0.6× 154 3.1k
J. M. van Rossum Netherlands 20 986 1.0× 625 1.0× 504 0.9× 177 0.6× 148 0.9× 46 2.2k
B. Ljunggren Sweden 30 705 0.7× 532 0.9× 368 0.7× 51 0.2× 115 0.7× 90 2.8k

Countries citing papers authored by R. Massingham

Since Specialization
Citations

This map shows the geographic impact of R. Massingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Massingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Massingham more than expected).

Fields of papers citing papers by R. Massingham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Massingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Massingham. The network helps show where R. Massingham may publish in the future.

Co-authorship network of co-authors of R. Massingham

This figure shows the co-authorship network connecting the top 25 collaborators of R. Massingham. A scholar is included among the top collaborators of R. Massingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Massingham. R. Massingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christophe, B., et al.. (2003). Histamine H 1 -agonist properties of histaprodifen derivatives on guinea-pig isolated trachea and ileum. Inflammation Research. 52(0). s51–s52. 4 indexed citations
2.
Diouf, Oumar, Michel Gelbcke, Patrice Talaga, et al.. (2002). A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold. Bioorganic & Medicinal Chemistry Letters. 12(18). 2535–2539. 8 indexed citations
3.
Gillard, Michel, et al.. (2002). Binding Characteristics of Cetirizine and Levocetirizine to Human H1Histamine Receptors: Contribution of Lys191and Thr194. Molecular Pharmacology. 61(2). 391–399. 171 indexed citations
4.
Massingham, R., et al.. (1997). In vitro calcium antagonistic and antioxidant effects of Org 13061 and its enantiomers, new potential antiatherosclerotic compounds. Fundamental and Clinical Pharmacology. 11(5). 416–426. 2 indexed citations
5.
Winslow, E., et al.. (1995). Lack of efficacy of 5‐HT2A receptor antagonists to reduce brain damage after 3 minutes of transient global cerebral ischaemia in gerbils. Fundamental and Clinical Pharmacology. 9(6). 562–568. 4 indexed citations
6.
John, Gareth W., et al.. (1995). Failure of Calcium Channel Blockade to Reduce Platelet-Mediated Cyclic Flow Variations in Dogs with Coronary Stenosis and Endothelial Injury. Journal of Cardiovascular Pharmacology. 26(4). 577–583. 5 indexed citations
7.
8.
John, Gareth W., et al.. (1991). Caffeine-induced contractions in rabbit isolated renal artery are differentially inhibited by calcium antagonists. European Journal of Pharmacology. 196(3). 307–312. 3 indexed citations
9.
Massingham, R., et al.. (1990). Studies on the activity of bepridil as a scavenger of free radicals. Biochemical Pharmacology. 40(7). 1615–1622. 41 indexed citations
10.
Poignet, H., et al.. (1989). Functional, Behavioral, and Histological Changes Induced by Transient Global Cerebral Ischemia in Rats: Effects of Cinnarizine and Flunarizine. Journal of Cerebral Blood Flow & Metabolism. 9(5). 646–654. 35 indexed citations
11.
Massingham, R., et al.. (1989). Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem. British Journal of Pharmacology. 98(4). 1351–1359. 10 indexed citations
12.
Massingham, R. & P. A. van Zwieten. (1989). Berpidil: A pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia. Cardiovascular Drugs and Therapy. 3(5). 731–742. 9 indexed citations
13.
Massingham, R.. (1982). Antihypertensive drugs: Some relationships between structure, activity and mechanisms of action. 68(9). 825–836. 1 indexed citations
14.
Shepperson, N B, et al.. (1982). Differential blocking effects of several dopamine receptor antagonists for peripheral pre- and postsynaptic dopamine receptors in the anesthetized dog.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 753–761. 33 indexed citations
15.
Massingham, R., M. L. Dubocovich, N B Shepperson, & Salomón Z. Langer. (1981). In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.. Journal of Pharmacology and Experimental Therapeutics. 217(2). 467–474. 50 indexed citations
16.
Shepperson, N B, et al.. (1981). Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 540–546. 42 indexed citations
17.
Cambridge, D., et al.. (1977). Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(3). 514P–515P. 116 indexed citations
18.
Blackburn, Kenneth J., et al.. (1977). UK-14,275, a novel orally-active cardiac stimulant [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 284P–285P. 4 indexed citations
19.
Daniel, E.E., R. Massingham, & P A Nasmyth. (1970). THE MECHANISM OF CONTRACTILE EFFECTS OF OUABAIN AND ZINC ON THE RAT UTERUS. Journal of Pharmacology and Experimental Therapeutics. 173(2). 293–307. 7 indexed citations
20.
Daniel, E. E., R. Massingham, & P A Nasmyth. (1968). An action of ouabain to promote smooth muscle contraction unrelated to membrane ATPase inhibition.. PubMed. 34(1). 231P–232P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuji Oguchi Breakdown of academic impact, for papers by A Giotti Breakdown of academic impact, for papers by G. Zürcher Breakdown of academic impact, for papers by J B Farmer Breakdown of academic impact, for papers by Jan M. Van Nueten Breakdown of academic impact, for papers by Kazutaka Momose Breakdown of academic impact, for papers by Hsien C. Cheng Breakdown of academic impact, for papers by Stefano Evangelista Breakdown of academic impact, for papers by J. M. van Rossum Breakdown of academic impact, for papers by B. Ljunggren
Rankless by CCL
2026